✓ Last verified: February 17, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Greenbrook TMS’s West Hartford center serves the greater Hartford area with FDA-cleared depression treatments including Spravato® (esketamine) nasal spray and NeuroStar® TMS therapy. As part of a national network of mental wellness centers, the West Hartford location provides standardized, evidence-based treatment protocols with broad insurance acceptance, making advanced depression therapies more accessible to Connecticut residents.
| Google Reviews | ⭐ National chain – Positive patient feedback |
| Location | West Hartford, Connecticut |
| Address | 836 Farmington Avenue, Suite 109, West Hartford, CT 06119 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | Spravato® (Esketamine) Nasal Spray, NeuroStar® TMS Therapy |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder |
| Cost | Covered by most insurance plans |
| Insurance | Most major insurance accepted for both TMS and Spravato® |
| KAP Available | Spravato® (esketamine) only – No IV ketamine or KAP |
| Clinical Lead | Greenbrook medical team with board-certified psychiatrists |
HealingMaps Take: Greenbrook TMS West Hartford offers the same strong insurance-covered Spravato® and TMS platform as their other Connecticut locations. The Farmington Avenue location is conveniently situated for Hartford-area residents seeking FDA-approved depression treatments without the financial burden of cash-pay ketamine infusions. Like all Greenbrook locations, this center does not offer IV ketamine or ketamine-assisted psychotherapy — but for patients whose primary need is Spravato® with insurance coverage, it’s a reliable and well-structured option.
Market Position: Greenbrook TMS West Hartford is a Spravato-certified clinic in the Hartford metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
Industry pricing reference. Greenbrook TMS West Hartford’s posted price: Covered by most insurance plans. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Connecticut, state-level prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
Depression is the #1 condition cited in 20.9% of HealingMaps ketamine inquiries, followed by PTSD (13.5%) and anxiety (11.4%) — the three together account for nearly half of all patient demand. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 2-question summary is matched to the protocols and conditions Greenbrook TMS West Hartford treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Greenbrook TMS West Hartford offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Greenbrook TMS West Hartford treats depression via Spravato (FDA-cleared for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
TMS therapy is also available at this clinic. Unlike cash-pay ketamine, TMS is covered by most major insurance plans for treatment-resistant depression. TMS is FDA-cleared for treatment-resistant depression (since 2008), OCD via Deep TMS, anxious depression, and adolescent MDD ages 15–21. This clinic uses BrainsWay Deep TMS, the only TMS device with standalone FDA clearance for OCD via the H7 coil. Read our complete guide to TMS therapy for FDA-cleared conditions, device differences, insurance coverage by carrier, and what to expect at your first appointment. Browse verified TMS clinics in our directory.
Leave a Reply